| ID Source | ID |
|---|---|
| PubMed CID | 65885 |
| CHEMBL ID | 2104348 |
| SCHEMBL ID | 637042 |
| MeSH ID | M0162665 |
| Synonym |
|---|
| ecabamide |
| muralis |
| ecabapide |
| dq-2511 |
| m-((((3,4-dimethoxyphenethyl)carbamoyl)methyl)amino)-n-methylbenzamide |
| benzamide, 3-((2-((2-(3,4-dimethoxyphenyl)ethyl)amino)-2-oxoethyl)amino)-n-methyl- |
| ccris 7698 |
| ecabapide [inn] |
| dq2511 |
| dq 2511 |
| 3-((2-((2-(3,4-dimethoxyphenyl)ethyl)amino)-2-oxoethyl)amino)-n-methylbenzamide |
| AKOS000279039 |
| 3-[[2-[2-(3,4-dimethoxyphenyl)ethylamino]-2-oxoethyl]amino]-n-methylbenzamide |
| 104775-36-2 |
| unii-4ka5whl8t2 |
| 4ka5whl8t2 , |
| CHEMBL2104348 |
| ecabapide [mi] |
| ecabapide [jan] |
| SCHEMBL637042 |
| Z52799962 |
| MLS006011526 |
| smr004703298 |
| DTXSID80146718 |
| SR-01000945217-1 |
| sr-01000945217 |
| FT-0720607 |
| Q27259863 |
| EN300-1700036 |
| 3-[({[2-(3,4-dimethoxyphenyl)ethyl]carbamoyl}methyl)amino]-n-methylbenzamide |
| Excerpt | Reference |
|---|---|
| "Ecabapide (DQ-2511) has been demonstrated to be effective in preventing water-immersion restraint stress ulceration of rats. " | ( Furuhama, K; Hosokami, T; Tabuchi, Y, 1995) |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (8.00) | 18.7374 |
| 1990's | 22 (88.00) | 18.2507 |
| 2000's | 1 (4.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (3.85%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 25 (96.15%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Article | Year |
|---|---|
| Thirteen-week repeated oral dose toxicity study of ecabapide, a gastroprokinetic drug, in dogs and rats. The Journal of toxicological sciences, Volume: 23 Suppl 3 | 1998 |
| [information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | |
| Article | Year |
|---|---|
| Thirteen-week repeated oral dose toxicity study of ecabapide, a gastroprokinetic drug, in dogs and rats. The Journal of toxicological sciences, Volume: 23 Suppl 3 | 1998 |
| A possible mechanism of heinz body hemolytic anemia induced by DQ-2511, a new gastroprokinetic drug, in dogs. Fundamental and applied toxicology : official journal of the Society of Toxicology, Volume: 32, Issue: 2 | 1996 |
| Cardiovascular properties of the new anti-ulcer drug 3-[[[2-(3,4-dimethoxyphenyl)ethyl]carbamoyl]methyl]-amino-N- methylbenzamide. Arzneimittel-Forschung, Volume: 43, Issue: 5 | 1993 |
| Identification of urinary metabolites of ecabapide in rat. Xenobiotica; the fate of foreign compounds in biological systems, Volume: 25, Issue: 5 | 1995 |
| [information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | |